Hertility was founded with a vision to bring reproductive science out of the lab and into the hands of every single woman worldwide.
In just 3 years, we've grown a team of 40+ and investigated every facet of gynae and hormonal health, from menstruation through menopause. The result? A personalised blood test and comprehensive symptom checker delivered to your door.
At present, we can predict and diagnose over 18 conditions relating to reproductive health via an online health assessment, at-home blood test and specialist clinical services.
Our growth is a testament to how needed this is. In FY23 our revenue has grown circa 520% YoY, reaching £1.2m in revenue for the 10 months to Jan’23.
We’re fostering a social community of over 1 million people who, for the first time ever, now understand what’s going on inside their bodies.
With over 1.5 billion people living with a gynaecological condition and more than half a million waiting for gynae appointments on the NHS, we're increasing access to women’s healthcare, both direct-to-consumer and to organisations as an employee benefit.
Ultimately—our revenue fuels our research. With every test taken, we are changing the lives of millions and the attitudes of all. We’re revolutionising women’s health once and for all.
We are more than 'femtech', we are building a fempire.
.png "HubSpot Squares (2)")
.png "Hertility UGC 3")
.png "HubSpot Squares (1)")
.png "TIle 1 (2)")
.svg "bloomberge (1)")
.png "Hubspot_Press Logos (1)")
